Skip to main content
. Author manuscript; available in PMC: 2009 Jul 1.
Published in final edited form as: Curr Drug Metab. 2009 Jan;10(1):29–40. doi: 10.2174/138920009787048428

Fig. (3).

Fig. (3)

Growth curve of H. pylori incubated with soluble CD43 having α1,4-GlcNAc-capped O-glycan (αGlcNAc (+)) and soluble CD43 lacking this O-glycan (αGlcNAc (−)). One milliunit (mU) of αGlcNAc (+) is defined as 1 μg of GlcNAcα-PNP. The protein concentration of αGlcNAc (−) is the same as that of 31.2 mU/ml of αGlcNAc (+). Adapted with permission from Kawakubo, M.; Ito, Y.; Okimura, Y.; Kobayashi, M.; Sakura, K.; Kasama, S.; Fukuda, M.N.; Fukuda, M.; Katsuyama, T.; Nakayama, J. Science, 2004, 305(5686), 1003–1006.